Deletion of ATM in mouse models of lung cancer and pancreatic cancer also induced sensitivity to PARP inhibitors and/or DNA damaging agents, as did inhibitors of the related protein kinase ATR (ATM and Rad3-related) [57,58]. The gene discussed is PARP1; the disease is pancreatic neoplasm.